SoFi Technologies and Nautilus Biotechnology Both Beat Q3 Earnings Estimates

The Quick Take

• SoFi Technologies beat Q3 earnings expectations with strong revenue growth, demonstrating continued momentum in its digital banking and lending operations
• Nautilus Biotechnology exceeded Q3 estimates with revenue growth driven primarily by grant funding, reflecting early-stage platform validation in its proteomics business
• Both companies delivered above-estimate results from very different business model stages

SoFi Technologies beat Q3 earnings expectations with strong revenue growth, affirming the digital bank's continued execution on its strategy to diversify beyond its student loan refinancing origins. SoFi's expansion into personal lending, financial planning, and banking products has driven sustained revenue momentum, and the Q3 beat suggests that the company's multi-product platform is generating durable demand. With SoFi now holding a national bank charter and building scale in deposit-funded lending, each earnings beat reinforces the platform's commercial viability in an increasingly competitive digital banking landscape.

Nautilus Biotechnology also beat Q3 estimates, with revenue growth driven by grant funding that reflects external scientific validation of its next-generation proteomics platform. As a pre-commercial biotech operating in single-molecule protein analysis, Nautilus's near-term financial performance is heavily influenced by research partnerships and non-dilutive grant funding from academic and government sources, making grant-driven beats a meaningful signal of platform credibility. The company's proteomics technology targets the large and largely uncharted protein analysis market, which could prove transformative for drug discovery if the platform reaches commercial scale.

The contrast between SoFi's commercial-stage scaling and Nautilus's early-stage platform development illustrates the breadth of earnings beats the market processes each quarter — from revenue-driven commercial momentum to milestone-driven scientific progress. For investors managing across growth company stages, the distinction matters: SoFi's beat is a signal of compounding business execution, while Nautilus's beat is a validation data point in a long development timeline. Both outcomes represent positive near-term signals for their respective shareholder bases as Q3 earnings season continues.

Synthesized from 2 sources.